The NEXT-Cue AI software, which incorporates analysis of brain MRI scans, reportedly facilitates prognostic assessments of potential progression from mild cognitive impairment (MCI) to Alzheimer’s disease within five years.
|Articles|April 16, 1997
Sterling inks Direct Radiography deal
Sterling Diagnostic Imaging of Glasgow, DE, last week announced the signing of a seven-year, $10 million agreement to supply its Direct Radiography and PACS technology to a Canadian healthcare provider. The deal makes Atlantic Health Sciences (AHSC) of
Advertisement
Sterling Diagnostic Imaging of Glasgow, DE, last week announced the signing of a seven-year, $10 million agreement to supply its Direct Radiography and PACS technology to a Canadian healthcare provider. The deal makes Atlantic Health Sciences (AHSC) of Saint John, New Brunswick, one of the first commercial installations of Sterling's Direct Radiography technology.
Under the agreement, Sterling will supply a second-generation Linx network to six AHSC facilities spread over a 250-km area. The installation will include image management workstations supplied by Sterling partner ISG Technologies of Mississauga, Ontario.
Once the network is in place, Sterling will integrate its Direct Radiography selenium-based digital image capture system into the network when DR is commercially available in early 1998. Sterling officials say the installation is notable in that it will represent a model for how DR can be integrated into PACS networks.
Advertisement
Related to this article
In a new podcast episode, Amir Iravani, MD, FRACP, discusses emerging dosimetry data from the COMPETE trial for 177Lu-edotreotide and how it may help facilitate more personalized treatment for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
In a recent interview, Phillip Koo, MD, discussed emerging trends with AI, theranostics and empowered patients, and how these developments may lead to challenges and potential opportunities for radiologists and nuclear medicine physicians.
AI has to do more than show potential. It has to deliver measurable results.The Rad AI Outcomes and Market Impact Compendium brings together real-world clinical, operational and financial evidence from health systems, academic medical centers and radiology practices using Rad AI Reporting, Impressions and Continuity.Explore results including 60+ minutes saved per radiologist shift, a 47% reduction in report error rates, 70%+ patient follow-up adherence and >7x ROI — plus, case studies showing how organizations are translating AI into greater capacity, quality and financial performance.See what AI built specifically for radiology can deliver in practice.
Catch up on the top radiology content of the past week.
Assessing breast MRI scans, pathology and clinical data, the AI-powered TumorSight Risk software reportedly provides five- and 10-year risk for breast cancer recurrence for women with HR+, HER2-negative stage I-IIIA breast cancer.
While a new article raises provocative questions about the capability of photon-counting CT (PCCT) to perhaps replace diagnostic ICA, the real revolution with this modality is going beyond stenosis measurement to a renewed focus on the disease of atherosclerosis.
Catch up on the latest imaging research presented at the recent American Society for Radiation Oncology (ASTRO) Annual Meeting.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
The Reading Room Podcast: A Closer Look at New Research on 177Lu-Edotreotide for Treating GEP-NETs
2
How AI, Theranostics and More Empowered Patients Have Led to Significant Changes in Radiology
3
FDA Clears MRI-Based AI Software for Prognostic Evaluation of Patients with Mild Cognitive Impairment
4
See the Real-World Impact of AI in Radiology
5